Incorporation of native HCV E1E2 into a nanoparticle vaccine platform
These studies show that a well-characterized sE1E2 platform compatible with multiple genotypes can be coupled to nanoparticles for use as a vaccine candidate and sets the stage for further exploration of nanoparticles and other multivalent platforms for the development of E1E2-based vaccines.